scholarly journals Non ST Elevation Myocardial Infarction after an Allergic Reaction: Type II Kounis Syndrome

2014 ◽  
Vol 5 (1) ◽  
pp. 1-4 ◽  
Author(s):  
Ahmet Oguz Baktir ◽  
Bahadir Sarli ◽  
Hayrettin Saglam ◽  
Huseyin Arinc ◽  
Mustafa Oguz Cumaoglu ◽  
...  
2021 ◽  
Vol 15 (9) ◽  
pp. 3040-3042
Author(s):  
Mubashir Kolachi ◽  
Zahid Naseeb Ansari ◽  
Tahir Hussain ◽  
Imran Karim ◽  
Muhammad Khan Soomro ◽  
...  

Objective: To determine the frequency of modifiable and non-modifiable risk factors of acute ST elevation myocardial infarction at tertiary care Hospital. Methods: This study was conducted in the department of Cardiology, Liaquat University Hospital Jamshoro, from July 2019 to January 2020. All the patients those presented with myocardial infarction and either of gender were included in the study. After taking complete clinical examination and diagnosis, patients were interviewed regarding family history, hypertension, diabetes, smoking, alcohol consumption, dietary habits and life style activities. Non modifiable predisposing risk factors were defined as age, gender and family history. Modifiable risk factors were defined as elevated serum cholesterol, presence of type II DM, cigarette smoking, obesity, a sedentary lifestyle and hypertension. All the data was recorded in self-made proforma. Data analysis was done by SPSS version 21 Results: Total 100 patients were studied; most common age group was 41-50 years (45.0%), and 51-60 years (35.0%). According to the types of myocardial infarction, Acute anterior wall MI was in 25.0%, Acute inferior MI was in 20.0%, EXT ANT WALL MI was in 16.0% and Acute inferior +RV MI was in 15.0% of patients. Elevated age in 70.0% and male gender in 69% of cases were found to be most common non-modifiable risk factors, while frequently seen Modifiable risk factors were smoking, type II diabetes, hypercholesteremia, hypertension, and physical activities. Conclusion: It was observed that elevated age, male gender, smoking, diabetes and hypertension are frequent risk factors for ST elevation myocardial infarction. Keywords: Modifiable, non-modifiable, risk factors, MI


Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
ANDREEA-CONSTANTA STAN ◽  
Momcilo Durdevic ◽  
Rosario Florante ◽  
Arshavir Artashesyan ◽  
Henrik Elenius ◽  
...  

Background: The presence of cardiovascular complications were reported in small studies of critical care patients admitted with SARS-CoV-2infection There is a dearth of data regarding presence of acute coronary syndromes (ACS) in patients admitted with symptomatic SARS-CoV-2 infection, the cause of the myocardial injury and particularities of management. Objectives: The aim of the study is to describe the presence and type ACS in patients admitted with symptomatic SARS-CoV-2 infection. Secondary outcomes were contributing factors, presenting symptoms and medical management. Methods: A descriptive, retrospective study of patients with a positive COVID-19 test and symptomatic infection admitted from 10 March 2020 to 10 April 2020 in our hospital. Results: There were a total of 127 patients admitted with symptomatic SARS-CoV-2 infection. The most common ACS was Type II Myocardial Infarction (MI). 16 patients were diagnosed with type II MI, 3 patients with Non ST elevation myocardial infarction (NSTEMI) and no patient was diagnosed with unstable angina and ST elevation myocardial infarction (STEMI). The most common cause of Type II MI was hypoxia followed by congestive heart failure and new onset atrial fibrillation. One patient has chest pain as presenting symptom. Except for Aspirin loading and use of beta blocker no other antischemic, statin or ACE/ARB medication was used for management of type II MI. All patients with Type II MI were managed by primary care teams. 3 patients developed NSTEMI and were managed by primary care teams with Cardiology consults. Anti-coagulation was considered for all patients. All patients received Aspirin loading, high intensity statin and beta blockers. Conclusions: Majority of patients with ACS had symptoms related to SARS-CoV-2 infection and chest pain was absent in 95% of cases. The most common ACS was type II MI- myocardial ischemia in context of hypoxia and the treatment was focused in treating the underlying cause rather than initiation of classical guideline directed therapy or invasive management. There were no cases of unstable angina and STEMI, results consistent with previous studies underlying the low incidence of STEMI cases during this pandemic.


2015 ◽  
Vol 24 (4) ◽  
pp. e48-e50 ◽  
Author(s):  
Dmitriy Scherbak ◽  
Mohamad Lazkani ◽  
Nick Sparacino ◽  
Akil Loli

2016 ◽  
Vol 29 (3) ◽  
pp. 298-300 ◽  
Author(s):  
Joseph R. Pelli ◽  
J. Scott Wieters ◽  
Bahrom Firozgary ◽  
Timothy Montalvo

JRSM Open ◽  
2021 ◽  
Vol 12 (8) ◽  
pp. 205427042110252
Author(s):  
Ossama Maadarani ◽  
Zouheir Bitar ◽  
Mahmoud Elzoueiry ◽  
Mohammad Nader ◽  
Mohamad Abdelfatah ◽  
...  

A case of ST elevation myocardial infarction reported post Coronavirus disease 2019 (COVID-19) vaccine. Probably premature to draw a link between COVID-19 vaccine and myocardial infarction.


2016 ◽  
Vol 6 (5) ◽  
pp. 466-468 ◽  
Author(s):  
Mohammad Reza Karimlu ◽  
Aida Alavi-Moghaddam ◽  
Omid Rafizadeh ◽  
Arsalan Azizpour ◽  
Isa Khaheshi

Sign in / Sign up

Export Citation Format

Share Document